Log In
Print
BCIQ
Print
Print this Print this
 

ALN-AT3

  Manage Alerts
Collapse Summary General Information
Company Alnylam Pharmaceuticals Inc.
DescriptionRNAi therapeutic targeting antithrombin mRNA (AT3)
Molecular Target Anti-thrombin III (AT3) (SERPINC1)
Mechanism of ActionGene silencing
Latest Stage of DevelopmentPreclinical
IndicationHemophilia
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today